FibroScan® 630 Expert

Save up to 15% on the Echosens FibroScan® 630 Expert.

FibroScan® 630 Expert is a comprehensive, non-invasive solution for advanced liver disease assessment and management. Combining Liver Stiffness Measurement (LSM) by Guided VCTE®, Controlled Attenuation Parameter (CAP) and Spleen Stiffness Measurement (SSM) by VCTE®, it supports assessment of liver fibrosis, steatosis and portal hypertension at the point of care. Results inform diagnosis and monitoring alongside other biomarkers and clinical information.

Backed by 25 years of Echosens innovation, FibroScan® is supported by over 6,270 peer-reviewed publications and 250 international guidelines. FibroScan® is used by NHS Hepatology and Gastroenterology departments. It is also increasingly used in commissioned pathways as recommended by National Institute for Health and Care Excellence (NICE) HTG682 in Primary Care, and Community Diagnostic Centres. Liver Stiffness Measurement (LSM) and Spleen Stiffness Measurement (SSM) are featured extensively in the latest Baveno VIII portal hypertension guidelines.

Designed for high-volume hospital settings, FibroScan® 630 Expert with Guided VCTE® has embedded ultrasound guidance, improved ergonomics and high-speed processing power to support efficient examinations that can be performed by any company trained operator (physician, nurse, healthcare assistant). Imaging experience is not required to operate the device.

• LSM by Guided VCTE® – non-invasive validated technology to support liver fibrosis assessment. intuitive features support simplified scanning and faster examinations.
• Controlled Attenuation Parameter (CAP) measurement – supports assessment of liver steatosis.
• SSM by VCTE® – supports non-invasive assessment and monitoring of portal hypertension.
• Supports clinical decisions for Metabolic Dysfunction-Associated Steatohepatitis (MASH) diagnosis and aiding future treatment pathways, as outlined in current guidelines European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO), American Association for the Study of Liver Diseases (AASLD), British Association for the Study of the Liver (BASL) consensus report.
• Embedded ultrasound guidance – helps operators locate the spleen for measurement.
• High-speed processing, 19-inch touchscreen and washable touch keyboard – supports examination efficiency in busy clinical services.
• S+, M+ and XL+ probe compatibility – accommodates all patient body types and ages.
• Connect seamlessly with hospital Electronic Patient Record (EPR) system via FibroScan® Gateway.
• Dedicated support – installation, training and local support help teams establish and maintain their service.
• An ecosystem of solutions – developed by Echosens to support clinical decisions for physicians: Liver Health Management platform (LHM), Scores, Clinically validated interpretation Guide, myFibroScan® app, Echosens Academy.

This offer is over and above the standard discount available through the NHS Supply Chain framework agreement. The discount is a fixed term offer. Offer available while stock lasts.